Finally, Juric et al., reported that PTEN down-regulation was associated with resistance to the PI3K p110-alpha selective inhibitor BYL719, but not to the pan-PI3K inhibitor BKM120 in BC cell lines [25]. This evidence concerns the gene PTEN and breast cancer.